12:00 AM
 | 
Aug 21, 2000
 |  BC Week In Review  |  Company News  |  Other News

Novartis other research news

NOVN's Imutran Ltd subsidiary (Cambridge U.K.) and colleagues published in Nature that porcine endogenous retroviruses (PERV) are transcriptionally active and infectious cross-species in vivo after transplantation...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >